Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
29 hedge funds and large institutions have $26.9M invested in Apollo Endosurgery, Inc. in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
4% more funds holding
Funds holding: 28 → 29 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
11% less capital invested
Capital invested by funds: $30.1M → $26.9M (-$3.21M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$317K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$75.1K |
| 3 |
Renaissance Technologies
New York
|
+$23.4K |
| 4 |
GS
Gagnon Securities
New York
|
+$21.6K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$7.65K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$3.54M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$249K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$62K |
| 4 |
Bank of New York Mellon
New York
|
-$38K |
| 5 |
BlackRock
New York
|
-$5.99K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | -$62K | -18,987 | Closed |
|
|
27
Bank of New York Mellon
New York
| – | -$38K | -11,663 | Closed |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| – | -$1.59K | -503 | -83% |
|
29
Morgan Stanley
New York
| – | +$19 | +6 | +17% |
|
30
Barclays
London,
United Kingdom
| – | +$463 | +146 | New |
|
APEN Hedge Fund Activity: Q3 2019 in Review
29 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q3 2019, worth a combined $26.9M — down 11% from $30.1M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new APEN positions and 2 closed out — a net gain of 2 holders — while 8 added to existing stakes and 5 trimmed.
The largest buyer was Vanguard Group, adding an estimated $317K. The largest seller was Stonepine Capital Management, cutting an estimated $3.54M.
- 29 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q3 2019, up from 28 in Q2 2019.
- Funds reported $26.9M of Apollo Endosurgery, Inc. stock for Q3 2019, down 11% quarter-over-quarter.
- 4 funds opened new Apollo Endosurgery, Inc. positions in Q3 2019 and 2 closed out, a net change of +2 holders.
- The largest Apollo Endosurgery, Inc. buyer in Q3 2019 was Vanguard Group, an estimated $317K added.
- The largest Apollo Endosurgery, Inc. seller in Q3 2019 was Stonepine Capital Management, an estimated $3.54M sold.
Based on aggregated 13F filings for Q3 2019.